Ethyl 2-(7-fluoro-1H-indol-3-yl)acetate

Catalog No.: 
ACIKMX347
CAS No.: 
1601476-86-1
Molecular Formula: 
C12H12FNO2
Molecular Weight: 
221.23
Ethyl 2-(7-fluoro-1H-indol-3-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$395.00InquiryInquiry
1g95%$988.00InquiryInquiry
5g95%$2964.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(7-fluoro-1H-indol-3-yl)acetate
IUPAC Nameethyl 2-(7-fluoro-1H-indol-3-yl)acetate
MDL No.MFCD28590728
Molecular FormulaC12H12FNO2
Molecular Weight221.23
SMILESFC(C=CC=C12)=C1NC=C2CC(OCC)=O
InChI KeyJLVWAIDILDMPQZ-UHFFFAOYSA-N
SynonymEthyl 7-Fluoroindole-3-acetate;1H-Indole-3-acetic acid, 7-fluoro-, ethyl ester;ethyl 2-(7-fluoro-1H-indol-3-yl)acetate
CAS No.1601476-86-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIKMX347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZLWH982 route compound structure diagram
    ACZLWH9822924-15-4In Stock
  4. Then
  5. ACIKMX347 route product structure diagram
    ACIKMX3471601476-86-1
Inquiry

2. ACIKMX347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIKMX347 route product structure diagram
    ACIKMX3471601476-86-1
Inquiry

3. ACIKMX347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIKMX347 route product structure diagram
    ACIKMX3471601476-86-1
Inquiry

Comments (0)